QR код

<i>In Vivo</i> Evaluation of Sepigel-Based Meglumine Antimoniate and Amphotericin B for Cutaneous Leishmaniasis Treatment

Cutaneous leishmaniasis (CL) poses a significant public health concern in endemic regions due to its increasing prevalence and substantial impact on affected individuals. This disease is primarily caused by the <i>Leishmania</i> protozoa, which are transmitted through insect bites, and it manifests...

Повний опис

Збережено в:
Автори: Atteneri López-Arencibia, Carlos J. Bethencourt-Estrella, Diana Berenguer, Angélica Domínguez-de-Barros, M. Magdalena Alcover, Marcella Sessa, Lyda Halbaut, Roser Fisa, Ana Cristina Calpena-Campmany, A. Elizabeth Córdoba-Lanús, Jacob Lorenzo-Morales, Cristina Riera, José E. Piñero
Формат: Artigo
Мова:Inglês
Опубліковано: MDPI AG 2024-08-01
Серія:Pathogens
Предмети:
<i>Leishmania amazonensis</i>
<i>in vivo</i>
meglumine antimoniate
amphotericin B
Sepigel
Онлайн доступ:https://www.mdpi.com/2076-0817/13/8/712
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси